Bristol Myers Squibb

Company description

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in the discovery, development, licensing and manufacturing, marketing, distribution, and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology, and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals, and government entities. BMS provides its products in the US, Europe, and Japan. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, and the US.

Company details

City:
New York
Address:
430 E. 29th Street, 14 Floor, New York, 10016
Phone:

Participation in projects

Projects Transactions
List of the updates in which the company was involved

Company updates

  • September 21, 2022

    EDPR starts construction of 240 MW Cattlemen I solar PV project in Texas

    EDP Renewables North America has started the construction of its 240 MW Cattlemen I solar photovoltaic project located in Milam County in Texas, USA.  The Cattlemen I solar project has secured t...

    Read more
  • April 26, 2022

    Bristol Myers Squibb signs PPA with EDPR for 240 MW Cattlemen Solar Park in Milam County

    EDP Renewables SA (EDPR), through its fully owned subsidiary EDP Renewables North America LLC (EDPR NA), and Bristol Myers Squibb have executed a 15-year power purchase agreement (PPA) for a 60 MW por...

    Read more